Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Galimi · SciRah

Researcher profile · Semantic Scholar

F. Galimi

Share profile

F. Galimi — researcher profile on SciRah

h-index: 45
Works: 100
Citations: 9,151

Most-cited papers

Reversal of human cellular senescence: roles of the p53 and p16 pathways
Christian Beauséjour, A. Krtolica, F. Galimi, Masashi Narita +3 more
2003EMBO Journal1,463 citations Open access
Semantic Scholar
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.
A. Bertotti, G. Migliardi, F. Galimi, F. Sassi +24 more
2011Cancer Discovery904 citations Open access
Semantic Scholar
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer
A. Bardelli, S. Corso, A. Bertotti, S. Hobor +24 more
2013Cancer Discovery646 citations Open access
Semantic Scholar
CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ
S. Herzig, Susan A. Hedrick, Ianessa Morantte, Seung-Hoi Koo +2 more
2003Nature333 citations
Semantic Scholar
Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.
Chong Sun, S. Hobor, A. Bertotti, D. Zecchin +17 more
2014Cell Reports305 citations Open access
Semantic Scholar
Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates
G. Solinas, W. Naugler, F. Galimi, Myung-Shik Lee +1 more
2006Proceedings of the National Academy of Sciences of the United States of America293 citations Open access
Semantic Scholar
HER2 activating mutations are targets for colorectal cancer treatment
Shyam M. Kavuri, N. Jain, F. Galimi, F. Cottino +9 more
2015Cancer Discovery288 citations Open access
Semantic Scholar
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
C. Isella, F. Brundu, S. Bellomo, F. Galimi +12 more
2017Nature Communications273 citations Open access
Semantic Scholar
Fate of endogenous stem/progenitor cells following spinal cord injury
Laura L. Horky, F. Galimi, F. H. Gage, P. Horner
2006The Journal of comparative neurology273 citations Open access
Semantic Scholar
Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction (*)
L. Naldini, E. Vigna, A. Bardelli, A. Follenzi +2 more
1995Journal of Biological Chemistry266 citations Open access
Semantic Scholar
Astrocytes contribute to gamma oscillations and recognition memory
Hosuk Lee, A. Ghetti, A. Pinto-Duarte, Xin Wang +8 more
2014Proceedings of the National Academy of Sciences of the United States of America253 citations Open access
Semantic Scholar
Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro.
M. Grano, F. Galimi, G. Zambonin, S. Colucci +3 more
1996Proceedings of the National Academy of Sciences of the United States of America225 citations Open access
Semantic Scholar
Microvesicles Derived from Endothelial Progenitor Cells Enhance Neoangiogenesis of Human Pancreatic Islets
V. Cantaluppi, L. Biancone, Federico Figliolini, Silvia Beltramo +8 more
2012Cell Transplantation190 citations Open access
Semantic Scholar
Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas
G. Migliardi, F. Sassi, D. Torti, F. Galimi +14 more
2012Clinical Cancer Research188 citations Open access
Semantic Scholar
International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1.
G. Scagliotti, I. Vynnychenko, Keunchil Park, Y. Ichinose +14 more
2012Journal of Clinical Oncology185 citations Open access
Semantic Scholar
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
H. Kindler, D. Richards, L. Garbo, E. Garon +12 more
2012Annals of Oncology184 citations Open access
Semantic Scholar
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Xing Y. Woo, J. Giordano, Anuj Srivastava, Zi-Ming Zhao +58 more
2019Nature Genetics169 citations Open access
Semantic Scholar
Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF.
C. Boccaccio, G. Gaudino, G. Gambarotta, F. Galimi +1 more
1994Journal of Biological Chemistry167 citations Open access
Semantic Scholar
Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene.
Silvia Giordano, Z. Zhen, Enzo Medico, G. Gaudino +2 more
1993Proceedings of the National Academy of Sciences of the United States of America159 citations Open access
Semantic Scholar
Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
F. Galimi, D. Torti, F. Sassi, C. Isella +21 more
2011Clinical Cancer Research130 citations Open access
Semantic Scholar
Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors
F. Galimi, G. Bagnara, L. Bonsi, E. Cottone +3 more
1994Journal of Cell Biology129 citations Open access
Semantic Scholar
Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis.
S. Heger, C. Mastronardi, G. Dissen, A. Lomniczi +6 more
2007Journal of Clinical Investigation118 citations Open access
Semantic Scholar
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
E. Zanella, F. Galimi, F. Sassi, G. Migliardi +11 more
2015Science Translational Medicine114 citations Open access
Semantic Scholar
Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction
A. Bertotti, M. Burbridge, S. Gastaldi, F. Galimi +9 more
2009Science Signaling104 citations Open access
Semantic Scholar
Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES
C. Pastore, G. Picchio, F. Galimi, R. Fish +3 more
2003Antimicrobial Agents and Chemotherapy92 citations Open access
Semantic Scholar
Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
F. Galimi, Meenakshi Noll, Y. Kanazawa, Timothy P Lax +3 more
2002Blood86 citations Open access
Semantic Scholar
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer.
A. Cohn, J. Tabernero, J. Maurel, E. Nowara +14 more
2013Annals of Oncology85 citations Open access
Semantic Scholar
Hepatocyte Growth Factor Is a Regulator of Monocyte-Macrophage Function1
F. Galimi, E. Cottone, E. Vigna, N. Arena +4 more
2001Journal of Immunology82 citations Open access
Semantic Scholar
Antiangiogenic and Immunomodulatory Effects of Rapamycin on Islet Endothelium: Relevance for Islet Transplantation
V. Cantaluppi, L. Biancone, G. Romanazzi, Federico Figliolini +10 more
2006American Journal of Transplantation78 citations Open access
Semantic Scholar
Opportunities for the use of lentiviral vectors in human gene therapy.
F. Galimi, I. Verma
2002Current Topics in Microbiology and Immunology76 citations
Semantic Scholar
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype
B. Lupo, F. Sassi, M. Pinnelli, F. Galimi +28 more
2020Science Translational Medicine75 citations Open access
Semantic Scholar
Forced retinoic acid receptor α homodimers prime mice for APL-like leukemia
T. Sternsdorf, V. Phan, Mei Lin Maunakea, Corinne B Ocampo +6 more
200675 citations Open access
Semantic Scholar
Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal
M. Svensson, Martina Zoccheddu, Shen Yang, Gyrid Nygaard +27 more
2020Science Advances70 citations Open access
Semantic Scholar
A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
L. Paz-Ares, B. Bálint, R. De Boer, J. V. van Meerbeeck +10 more
2013Journal of Thoracic Oncology69 citations Open access
Semantic Scholar
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer
C. Fuchs, M. Fakih, L. Schwartzberg, A. Cohn +10 more
2013Cancer69 citations Open access
Semantic Scholar
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer
S. Gastaldi, F. Sassi, P. Accornero, D. Torti +9 more
2013Oncogene67 citations Open access
Semantic Scholar
Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
Roberta Giordo, Gheyath K Nasrallah, A. M. Posadino, F. Galimi +3 more
2021Antioxidants63 citations Open access
Semantic Scholar
The HIV-1 Nef Protein Interferes with Phosphatidylinositol 3-Kinase Activation 1 (*)
A. Graziani, F. Galimi, E. Medico, E. Cottone +3 more
1996Journal of Biological Chemistry55 citations Open access
Semantic Scholar
In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles
G. Dissen, A. Lomniczi, Tanaya L. Neff, T. Hobbs +4 more
2009Methods49 citations Open access
Semantic Scholar
Macrophage stimulating protein may promote tubular regeneration after acute injury.
V. Cantaluppi, L. Biancone, G. Romanazzi, Federico Figliolini +11 more
2008Journal of the American Society of Nephrology49 citations Open access
Semantic Scholar
MACC1 mRNA Levels Predict Cancer Recurrence After Resection of Colorectal Cancer Liver Metastases
C. Isella, A. Mellano, F. Galimi, Consalvo Petti +5 more
2013Annals of Surgery47 citations Open access
Semantic Scholar
Inhibition of Src Impairs the Growth of Met-Addicted Gastric Tumors
A. Bertotti, C. Bracco, F. Girolami, D. Torti +6 more
2010Clinical Cancer Research47 citations Open access
Semantic Scholar
The hepatocyte growth factor and its receptor
F. Galimi, M. Brizzi, P. Comoglio
1993Stem Cells47 citations
Semantic Scholar
Preclinical Antitumor Activity of a Novel Anti–c-KIT Antibody–Drug Conjugate against Mutant and Wild-type c-KIT–Positive Solid Tumors
T. Abrams, Anu V. Connor, C. Fanton, Steven B. Cohen +23 more
2018Clinical Cancer Research46 citations Open access
Semantic Scholar
Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia.
T. Sternsdorf, V. Phan, Mei Lin Maunakea, Corinne B Ocampo +6 more
2006Cancer Cell45 citations
Semantic Scholar
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours
V. Martin, C. Chiriaco, Chiara Modica, A. Acquadro +8 more
2019British Journal of Cancer40 citations Open access
Semantic Scholar
Development of ecdysone-regulated lentiviral vectors.
F. Galimi, E. Saez, J. Gall, Nien Hoong +3 more
2005Molecular Therapy40 citations Open access
Semantic Scholar
A phase 1 study of ADI-001: Anti-CD20 CAR-engineered allogeneic gamma delta (γδ) T cells in adults with B-cell malignancies.
S. Neelapu, M. Hamadani, D. Miklos, H. Holmes +7 more
2022Journal of Clinical Oncology37 citations
Semantic Scholar
A role for bone marrow-derived cells in the vasculature of noninjured CNS.
F. Galimi, R. Summers, H. van Praag, I. Verma +1 more
2005Blood31 citations
Semantic Scholar
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab
J. Tabernero, S. Chawla, Hedy L. Kindler, K. Reckamp +8 more
2014Targeted oncology30 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Comoglio×16
Invite
P. Comoglio — researcher profile on SciRah
A. Bertotti×14
Invite
A. Bertotti — researcher profile on SciRah
L. Trusolino×13
Invite
L. Trusolino — researcher profile on SciRah
E. Medico×10
Invite
E. Medico — researcher profile on SciRah

×7

Invite

G. Migliardi — researcher profile on SciRah

Invite

C. Isella — researcher profile on SciRah

Invite

F. Sassi — researcher profile on SciRah

Invite

D. Torti — researcher profile on SciRah

C. Boccaccio×6

Invite

C. Boccaccio — researcher profile on SciRah

Invite

A. Bardelli — researcher profile on SciRah

Invite

Y. Hei — researcher profile on SciRah

F. Di Nicolantonio×4

Invite

F. Di Nicolantonio — researcher profile on SciRah